Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This 12-week randomized, open-label study evaluates the efficacy and safety of Tacrolimus
combined with Glucocorticoid for Sjogren's syndrome patients with severe thrombocytopenia.